Back to Search Start Over

Table S5 from PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype

Authors :
Pierfranco Conte
Aleix Prat
Roberto D'Amico
Nuria Chic
Laia Paré
Loredana Urso
Matteo Curtarello
Gaia Griguolo
Enrico Orvieto
Federico Piacentini
Oriana Nanni
Katia Cagossi
Elena Bertone
Ornella Garrone
Anita Rimanti
Francesco Giotta
Antonino Musolino
Luigi Cavanna
Antonio Frassoldati
Alba A. Brandes
Giancarlo Bisagni
Maria Vittoria Dieci
Valentina Guarneri
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Additional prognostic value (DFS) of TILs, PIK3CA mutation, PDCD1 expression and MYBL2 expression to integrated prognostic models.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....a21010f72531f68fa38e46cf2b2bcd09